BioWorld MedTech

Dec. 24, 2013

First patient receives fully implantable heart from French-based Carmat

PARIS – A 75-year old Frenchman was alert and joking with doctors the day after receiving a fully implantable bioprosthetic heart in a 10-hour operation at the Georges Pompidou European Hospital (Paris) on Dec. 18. Read More

FINANCINGS ROUNDUP: CSA Medical closes $16M Series C funding round

Intact starts enrollment for TOBA-BTK pilot study

Report cites inconsistencies in reviews of device applications

DEALS ROUNDUP: PTS acquires A1CNow and expands product portfolio

HIT ROUNDUP: CareCloud Charts meets ONC's Complete EHR 2014 criteria

RESTRUCTURING ROUNDUP: NuVasive Manufacturing to expand workforce by more than 25% in '14

People in the News:

Product Briefs:

Keeping you up to date with recent developments in Cardiology

Today's news in brief

BioWorld

BioWorld briefs for Dec. 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 12, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...